TAPUR

The Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Objective

The purpose of the study is to learn from the real-world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug.

NCT#02693535

Clinical Trial Categories

• Other

Contact

NH Oncology Hematology Clinical Research Dept. at (603) 224-2556